Trials Sponsors Conditions Drugs Pricing

Conditions

Fatigue Hemolysis Inflammation Iron Deficiency Oxidative Stress Sports Anemia

Outcome Measures

Primary Outcomes (4)

Hematological parameters
Complete blood counts and serum haptoglobin and erythropoietin
Through study completion, an average of 1 year
Iron status
Serum iron, ferritin, transferrin and hepcidin
Through study completion, an average of 1 year
Oxidative stress
Thiobarbituric acid reactive substances, superoxide dismutase, catalase, and glutathione peroxidase
Through study completion, an average of 1 year

Study Arms (2)

Danggui Buxue Tang group

EXPERIMENTAL

Danggui Buxue Tang group receive orally supplementation of 7.5 g/day of Danggui Buxue Tang for 10 days

Dietary Supplement: Danggui Buxue Tang

Placebo group

PLACEBO COMPARATOR

Placebo group receive orally supplementation of 7.5 g/day of placebo for 10 days

Other: Placebo

Interventions

Danggui Buxue TangDietary supplement

Danggui Buxue Tang purchased from Kaiser Pharmaceutical

Danggui Buxue Tang group

PlaceboOther

Consisting of corn starch and carboxymethyl cellulose

Placebo group

Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.

Eligibility Criteria

Age20 Years - 30 Years

Sexmale

Healthy VolunteersYes

Age GroupsAdult (18-64)

You may qualify if:

The participants should have the experience finishing 10-km run but without the experience of attending a marathon run.

You may not qualify if:

Sponsors & Collaborators

Kaohsiung Medical University Chung-Ho Memorial Hospital
Otherlead

Study Sites (1)

Kaohsiung Medical University

Kaohsiung City, 807, Taiwan

MeSH Terms

Conditions

InflammationIron DeficienciesHemolysisFatigue

Interventions

danggui buxue decoction

Condition Hierarchy (Ancestors)

Pathologic ProcessesPathological Conditions, Signs and SymptomsIron Metabolism DisordersMetabolic DiseasesNutritional and Metabolic DiseasesSigns and Symptoms

Enrollment

39 participants (actual enrollment reported by the registry).

Study Design

Study Type: interventional
Phase: not applicable
Allocation: RANDOMIZED
Masking: SINGLE
Who Masked: PARTICIPANT
Purpose: TREATMENT
Intervention Model: PARALLEL
Sponsor Type: OTHER
Responsible Party: SPONSOR

Study Record Dates

First Submitted

December 11, 2016

First Posted

December 19, 2016

Study Start

October 2016

Actual (reported)

Effects of Danggui Buxue Tang on Blood Biochemical Parameters in Male Recreational Runners

Brief Summary

Registry Overview

Trial Relationships

Study Timeline

Study Start

First Submitted

First Posted

Primary Completion

Study Completion

Conditions

Outcome Measures

Primary Outcomes (4)

Study Arms (2)

Danggui Buxue Tang group

Placebo group

Interventions

Eligibility Criteria

You may qualify if:

You may not qualify if:

Sponsors & Collaborators

Study Sites (1)

MeSH Terms

Conditions

Interventions

Condition Hierarchy (Ancestors)

Enrollment

Study Design

Study Record Dates

Secondary Outcomes (1)

Data Sharing

Source record

Locations

Brief Summary

Registry Overview

Trial Relationships

Related Scientific Literature

Study Timeline

Study Start

First Submitted

First Posted

Primary Completion

Study Completion

Conditions

Outcome Measures

Primary Outcomes (4)

Study Arms (2)

Danggui Buxue Tang group

Placebo group

Interventions

Eligibility Criteria

You may qualify if:

You may not qualify if:

Sponsors & Collaborators

Study Sites (1)

MeSH Terms

Conditions

Interventions

Condition Hierarchy (Ancestors)

Enrollment

Study Design

Study Record Dates

Secondary Outcomes (1)

Data Sharing

Source record

Locations